John T. Cavan
Overview
John T. Cavan received $365K in total compensation, including $38K in salary, at Stemline Therapeutics in 2012.
Source: SEC filing on April 30, 2013.
Related executives
We found six more executives who work or worked at Stemline Therapeutics.
Ivan Bergstein
Stemline Therapeutics
Chief Executive Officer
Kenneth Hoberman
Stemline Therapeutics
Chief Operating Officer
Robert Francomano
Stemline Therapeutics
Chief Commercial Officer
David Gionco
Stemline Therapeutics
Chief Accounting Officer
Eric Rowinsky
Stemline Therapeutics
Chief Medical Officer
Stephen Hall
Stemline Therapeutics